Cell And Gene Therapy Manufacturing
-
CAR-T Innovation: Balancing Allogeneic And Autologous Cell Therapy
6/30/2025
Join experts as they discuss strategies for optimizing allogeneic and autologous therapies, aiming for balanced development and wider patient accessibility by 2030.
-
Inside Bioprocessing: Microbial Media
11/4/2025
Learn the reasons why the animal origin-free trend in bioprocessing has taken so long to reach microbial bioproduction and the technical hurdles overcome during the development of Gibco CD Bacto Supreme.
-
A Successful Journey To Cell Therapy Manufacturing
5/29/2025
Learn about the three main areas to consider when you're preparing to commercialize a cell therapy, including starting/raw material, the controlled manufacturing process, as well as testing safety and quality.
-
Accelerating Bioprocessing Success With Analytics
5/19/2025
This bioprocessing online webinar series talks about analytical solutions to help accelerate bioprocessing success. There are a variety of analytical options available to help you gain deeper insights on your cell culture process.
-
Advancing Gene Therapy Development With A Multi-Serotype AAV Resin
5/29/2025
In this webinar, leading CDMO ABL and Thermo Fisher will share data on implementation of the POROS™ CaptureSelect™ AAVX affinity resin into such an AAV purification platform, including its performance in purifying several serotypes.
-
AAV Purification: Solving Downstream Challenges
6/9/2025
In this roundtable discussion, a trio of distinguished experts in AAV purification and process development share their expertise and best practices in tackling and solving downstream challenges.
-
Focal Points for 2024: Dr. Verdun and Dr. Marks Talk Regulatory Challenges for Cell-Based Therapies
1/30/2024
Dr. Verdun and Dr. Marks provide detailed feedback on the regulatory challenges facing cell therapy and explain the Agency’s most important focal points for 2024, patient accessibility, and more.
-
Genentech, Myeloid's Approaches To mRNA Technologies
1/29/2024
Experts at a Cell & Gene Live event discussed the use of mRNA technology in cancer immunotherapy, including a brief overview of the different approaches being used to leverage mRNA technology.
-
Unlocking The Future Of Allogeneic Cell Therapy For Oncology | Audience Q&A
5/6/2024
Expert panelists in this Cell & Gene Therapy Live presentation provided detailed responses to questions about the potential risks of CAR-T therapy, screening criteria for donor material, comparability, and more.
-
Leveraging dPCR r Techniques To Quantitate Lentivirus Particles
5/28/2025
Discover how digital PCR can streamline lentiviral vector characterization to reduce variability and improve analytical sensitivity. Learn how this approach can help you comply with regulatory guidance.